Atmus Filtration Technologies Inc. Research and Development Expense
Atmus Filtration Technologies Inc. (ATMU) reported Research and Development Expense of $9.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Atmus Filtration Technologies Inc. research and development expense for the quarter ending 2026-06-30 was $9.80M, a 8.41% decline year-over-year.
- Atmus Filtration Technologies Inc. research and development expense for the quarter ending 2026-03-31 was $8.10M, a 10.99% decline year-over-year.
- Atmus Filtration Technologies Inc. research and development expense for the quarter ending 2025-12-31 was $10.90M, a 4.81% increase year-over-year.
- Atmus Filtration Technologies Inc. research and development expense for the quarter ending 2025-09-30 was $10.00M, a 3.09% increase year-over-year.
- Atmus Filtration Technologies Inc. research and development expense for fiscal 2025 was $40.70M, a 0.25% increase from fiscal 2024.
- Atmus Filtration Technologies Inc. research and development expense for fiscal 2024 was $40.60M, a 4.47% decline from fiscal 2023.
- Atmus Filtration Technologies Inc. research and development expense for fiscal 2023 was $42.50M, a 10.10% increase from fiscal 2022.
- Atmus Filtration Technologies Inc. research and development expense for fiscal 2022 was $38.60M, a 8.10% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.80M 10-Q · filed 2026-08-07 | $17.90M 10-Q · filed 2026-08-07 | $28.80M derived: sum of 3 quarters · filed 2026-08-07 | $38.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $8.10M 10-Q · filed 2026-05-01 | $19.00M derived: sum of 2 quarters · filed 2026-05-01 | $29.00M derived: sum of 3 quarters · filed 2026-05-01 | $39.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.90M derived: sum of 2 quarters · filed 2026-02-13 | $31.60M derived: sum of 3 quarters · filed 2026-08-07 | $40.70M 10-K · filed 2026-02-13 |
| 2025-09-30 | $10.00M 10-Q · filed 2025-11-07 | $20.70M derived: sum of 2 quarters · filed 2026-08-07 | $29.80M 10-Q · filed 2025-11-07 | $40.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $10.70M 10-Q · filed 2026-08-07 | $19.80M 10-Q · filed 2026-08-07 | $30.20M derived: sum of 3 quarters · filed 2026-08-07 | $39.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $9.10M 10-Q · filed 2026-05-01 | $19.50M derived: sum of 2 quarters · filed 2026-05-01 | $29.20M derived: sum of 3 quarters · filed 2026-05-01 | $39.60M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.10M derived: sum of 2 quarters · filed 2026-02-13 | $30.50M derived: sum of 3 quarters · filed 2026-02-13 | $40.60M 10-K · filed 2026-02-13 |
| 2024-09-30 | $9.70M 10-Q · filed 2025-11-07 | $20.10M derived: sum of 2 quarters · filed 2025-11-07 | $30.20M 10-Q · filed 2025-11-07 | $39.50M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $10.40M 10-Q · filed 2025-08-08 | $20.50M 10-Q · filed 2025-08-08 | $29.80M derived: sum of 3 quarters · filed 2026-02-13 | $40.90M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $10.10M 10-Q · filed 2025-05-02 | $19.40M derived: sum of 2 quarters · filed 2026-02-13 | $30.50M derived: sum of 3 quarters · filed 2026-02-13 | $42.80M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.40M derived: sum of 2 quarters · filed 2026-02-13 | $32.70M derived: sum of 3 quarters · filed 2026-02-13 | $42.50M 10-K · filed 2026-02-13 |
| 2023-09-30 | $11.10M 10-Q · filed 2024-11-08 | $23.40M derived: sum of 2 quarters · filed 2024-11-08 | $33.20M 10-Q · filed 2024-11-08 | $42.10M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $12.30M 10-Q · filed 2024-08-02 | $22.10M 10-Q · filed 2024-08-02 | $31.00M derived: sum of 3 quarters · filed 2025-02-21 | $40.80M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $9.80M 10-Q · filed 2024-05-03 | $18.70M derived: sum of 2 quarters · filed 2025-02-21 | $28.50M derived: sum of 3 quarters · filed 2025-02-21 | $38.00M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $18.70M derived: sum of 2 quarters · filed 2025-02-21 | $28.20M derived: sum of 3 quarters · filed 2025-02-21 | $38.60M 10-K · filed 2025-02-21 |
| 2022-09-30 | $9.80M 10-Q · filed 2023-11-03 | $19.30M derived: sum of 2 quarters · filed 2023-11-03 | $29.70M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $9.50M 10-Q · filed 2023-08-09 | $19.90M 10-Q · filed 2023-08-09 | ||
| 2021-12-31 | $42.00M 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dorman Products, Inc. (DORM) | United States | $3.641B | 18.26 |
| Versigent PLC (VGNT) | $3.205B | ||
| DANA Inc (DAN) | United States | $2.944B | 2.63 |
| GENTEX CORP (GNTX) | United States | $4.643B | 13.22 |
| Garrett Motion Inc. (GTX) | $4.732B | 9.95 | |
| VISTEON CORP (VC) | United States | $2.398B | 16.55 |
| PHINIA INC. (PHIN) | United States | $2.197B | 22.60 |
| PATRICK INDUSTRIES INC (PATK) | United States | $2.176B | 20.75 |
| LCI INDUSTRIES (LCII) | United States | $2.034B | 12.21 |
| LEAR CORP (LEA) | United States | $5.831B | 11.79 |